NCT06863818View on ClinicalTrials.gov

Overcoming Resistance to EGFR Neutralization by Combination of Monoclonal Antibodies and Novel Cancer Drugs

Active, not recruitingOBSERVATIONAL

Enrollment

30

Participants

Timeline

Start Date

October 10, 2022

Primary Completion Date

March 31, 2024

Study Completion Date

December 31, 2025

Conditions

Non Small Cell Lung Cancer

Trial Locations (1)

40138

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

All Listed Sponsors

lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER